Department of Urology, Kantonsspital Graubünden, Loësstr. 170, 7000, Chur, Switzerland.
Icahn School of Medicine at Mount Sinai, 625 Madison Avenue, New York, USA.
World J Urol. 2021 Jul;39(7):2255-2262. doi: 10.1007/s00345-021-03607-7. Epub 2021 Mar 27.
In 1926 Maximilian Stern introduced a new instrument to treat obstructions at the vesical orifice and baptized it resectoscope. With reference to astonishing historical statements about the new instrument and surgical technique made by the pioneers and their critics we will value why transurethral resection of the prostate (TURP) remains the gold standard for most men suffering from lower urinary tract symptoms (LUTS) due to benign prostatic enlargement. TURP is currently challenged by recently introduced new instruments and techniques claiming advantages over TURP. However, TURP offers an excellent balance between high efficacy in symptom relieve and low morbidity along with low costs and favorable long term outcome compared to other treatment options. We will outline these arguments demonstrating that even after a century has elapsed, since its introduction into the urologists armamentarium, TURP continues to stand the passage of time.
1926 年，Maximilian Stern 引入了一种新的仪器来治疗膀胱口的阻塞，并将其命名为电切镜。参考先驱者及其批评者关于新仪器和手术技术的惊人历史陈述，我们将评估为什么经尿道前列腺切除术（TURP）仍然是大多数因良性前列腺增生而出现下尿路症状（LUTS）的男性的金标准。TURP 目前受到最近引入的新仪器和技术的挑战，这些新技术声称比 TURP 具有优势。然而，与其他治疗选择相比，TURP 在缓解症状方面具有很高的疗效，同时具有较低的发病率、较低的成本和良好的长期效果，在疗效和安全性之间取得了很好的平衡。我们将概述这些论点，证明即使在引入泌尿科医生武器库一个世纪之后，TURP 仍然经得起时间的考验。
